June 9, 2026
Day 1 – From Science to Clinical and Applied Impact
Session 1
Advances in Phage Therapy: From Mechanisms to Clinical Translation
Opening Keynote Lecture
Turning Evolution into Therapy: A New Strategy to Fight Antibiotic-Resistant Infections
Turning Evolution into Therapy: A New Strategy to Fight Antibiotic-Resistant Infections
Benjamin K. Chan
Yale University, USA
Joana Azeredo
University of Minho, Portugal
Martin J. Loessner
ETH Zürich, Switzerland
Katrine Whiteson
UC Irvine, USA
Session 2
Phages Across One Health: Animal, Food, and Industry
Adelaide Almeida
Universidade de Aveiro, Portugal
Robert Atterbury
University of Nottingham, United Kingdom
Oscar Mencía-Ares
Universidad de León, Spain
Short Oral Presentations
June 10, 2026
Day 2 – Enablers for Scale, Access, and Impact
Session 3
Production, Regulation, and Market Access
Annika Y. Classen
Cologne University Hospital, Germany
Frédéric Laurent
Hospices Civils de Lyon, France
Juan Evaristo Suárez
Universidad de Oviedo, Spain
Danish J. Malik
Loughborough University, United Kingdom
Session 4
Innovation Forum: Building the Future of Phage Therapy
Paula Zamora
University of Kansas Medical Center, USA
Evgenii Rubalskii
Medizinische Hochschule Hannover, Germany
Short Oral Presentations
Closing Remarks
From Promise to Practice: What Will Make Phage Therapy Mainstream?
Phage therapy has entered a decisive decade. What we do now will determine whether it remains an opportunity or becomes a standard pillar of infectious disease medicine.
Short Oral Abstract Submission Deadline
May 9, 2026
Poster Abstract Submission Deadline
May 13, 2026